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Abstract.  We have examined the effects of 
topoisomerase inhibitors on the phosphorylation of 
histones in chromatin during the G2 and the M  phases 
of the cell cycle. Throughout the G2 phase of BHK 
cells, addition of the topoisomerase II inhibitor VM- 
26 prevented histone HI phosphorylation,  accompa- 
nied by the inhibition of intraceUular histone H1 ki- 
nase activity. However, VM-26 had no inhibitory 
effect on the activity of the kinase in vitro,  suggesting 
an indirect influence on histone H1 kinase activity. 
Entry into mitosis was also prevented, as monitored 
by the absence of nuclear lamina depolymerization, 
chromosome condensation,  and histone H3 phosphory- 
lation.  In contrast,  the topoisomerase I inhibitor, 
camptothecin,  inhibited histone H1 phosphorylation 
and entry into mitosis only when applied at early G2. 
In cells that were arrested in mitosis, VM-26 induced 
dephosphorylation of histones H1  and H3, DNA 
breaks, and partial chromosome decondensation. 
These changes in chromatin parameters probably re- 
verse the process of chromosome condensation,  un- 
folding condensed regions to permit the repair of 
strand breaks in the DNA that were induced by VM- 
26.  The involvement of growth-associated histone HI 
kinase in these processes raises the possibility that the 
cell detects breaks in the DNA through their effects on 
the state of DNA supercoiling in constrained domains 
or loops. It would appear that histone H1 kinase and 
topoisomerase II work coordinately in both chromo- 
some condensation and decondensation,  and that this 
process participates in the VM-26-induced G2 arrest 
of the cell. 
W 
'HEN cells of higher eukaryotes enter mitosis, the 
nucleus  undergoes  major  rearrangements  which 
include condensation of interphase  chromatin  into 
metaphase  chromosome,  breakdown of the nuclear  enve- 
lope, and the assembly of the mitotic spindle. An early event 
in this process is the G2 phase phosphorylation of histone 
H1 up to the hyperphosphorylated state at metaphase.  Such 
a  correlation  of histone phosphorylation  and  progression 
through  G2 was  first  observed in  the highly  synchronous 
slime mold, Physarum polycephalum, and led to the hypoth- 
esis that histone H1 phosphorylation could play a key role 
in the regulation of the cell cycle (4-6, 24). In the macroplas- 
modia of Physarum polycephalum there is a massive hyper- 
phosphorylation of histone H1 through G2 to M phase with 
22-24 phosphates/H1 molecule at metaphase (37). The phys- 
arum  H1,  however,  has  a  flexible  basic  COOH-terminal 
domain of 200 residues  compared to the  100 residues for 
mammalian  H1. In mammalian  cells,  there are zero to one 
phosphate per histone H1 during the G1 phase of the cell cy- 
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cle, and this increases  by another two phosphates during  S 
phase.  The level of phosphorylation then rises through  G2 
up to the hyperphosphorylated state of four to six phosphates 
per histone H1 at metaphase (17-19, 21). This correlation be- 
tween histone phosphorylation and chromosome condensa- 
tion  was also observed during  the induction  of premature 
chromosome condensation in sea urchin eggs and in mam- 
malian  cells  (1, 27). 
Advancement  of mitosis by up to 1 h was reported when 
partially purified heterologous histone H1 kinase was added 
to Physarum polycephalum 3 h before the onset of mitosis 
(6, 24). This advancement is very similar to the induction of 
mitotic events by the maturation  promoting factor (MPF) I 
which is active during late G2 (13, 27, 28, 35, 44). MPF has 
been identified with the growth-associated histone H1 kinase 
(GA kinase)  and is a complex of the kinase p34  c~c2 and the 
p62 cyclin  B  (2,  8,  9,  11,  12,  28,  43).  Microinjection of 
p34  °d°2 into mammalian  ceils was shown to induce chroma- 
tin condensation  along with other events indicative  of early 
phases of mitosis (30). Thus, the growth-associated histone 
HI kinase has a key role in the initiation of mitosis. However, 
1. Abbreviation  used in this paper:  MPE maturation promoting factor. 
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some condensation and its coordination with other mitotic 
events. 
Another major participant in mitosis is topoisomerase II. 
This enzyme can relax supercoiled DNA and resolve cate- 
hated and knotted DNA by transiently breaking and rejoin- 
ing both strands of DNA (51, 52).  Topoisomerase II was 
shown to be essential for the untangling of sister chromatids 
and chromosome separation during anaphase in yeast cells 
(22, 23, 49,  50).  In addition, in cstop2 mutant yeast cells, 
the chromosomes of the temperature-arrested cells are less 
compact than their normal counterparts and resemble pro- 
phase chromosomes in mammalian cells (49).  This suggests 
that topoisomerase II is required for the final condensation 
of chromosomes, but not for the initial stages. In an in vitro 
assay system using Xenopus  mitotic extracts and mammalian 
nuclei, Newport and Spann (39) showed that topoisomerase 
II inhibitors completely prevented condensation of chromo- 
somes.  This  inhibition occurred before prophase,  as evi- 
denced by the absence of visible chromosomes when exam- 
ined  under  light  microscopy.  Thus,  the  importance  of 
topoisomerase II in chromosome condensation and mitosis 
is clear although the details of its activity are unknown. It 
would appear that at least two major factors are involved in 
the  process  of chromosome condensation (a)  GA  kinase 
which governs the condensation of chromatin loops through 
histone  H1  phosphorylation;  and  (b)  topoisomerase  IIs 
which are located at the bases of loops and act on DNA to- 
pology. The interrelationships of these factors are not under- 
stood and are the subject of this study. 
The activity of topoisomerase II has been studied with 
VM-26, a well-characterized inhibitor of the enzyme (32). 
VM-26 does not have any DNA binding properties, making 
it a better choice over other inhibitors that act by intercalat- 
ing  DNA,  and could affect DNA  topology in chromatin 
loops.  VM-26  acts  by  stabilizing an  intermediate in  the 
topoisomerase reaction in which each monomer of the di- 
meric enzyme is covalently attac.hed  to the 5' ends of the 
double-stranded break in the DNA.  Topoisomerase II was 
shown to be the only protein associated with these DNA 
breaks (32). 
An important property of VM-26 is its high specificity. 
Previous studies have shown that cells are sensitive to VM- 
26 mainly in the S and G2 phases (16, 26, 36, 42, 45, 52), 
while at Go when little topoisomerase II is present, VM-26 
has no effect on the survival of the cells (46, 47).  Further- 
more, mutant cells that were isolated for resistance to VM- 
26 have altered topoisomerase II (48).  A  mutation in the 
gene coding for topoisomerase II was also reported in cells 
that are resistant to adriamycin, another topoisomerase II in- 
hibitor (7). These lines of  evidence point to a strong specific- 
ity of VM-26 to the enzyme. 
We have used VM-26 to inhibit topoisomerase II activity 
during the G2 and M phases of the cell cycle and monitored 
the effects on histone H1  kinase activity, on the levels  of 
phosphorylation in histones H1  and H3,  on chromosome 
condensation, and on nuclear envelope breakdown. Here we 
show that all these events are also affected by VM-26.  We 
discuss how these changes might result either from the inac- 
tivation of topoisomerase II itself or from the DNA breaks 
induced by the action of VM-26 on topoisomerase II, and 
how these changes might participate in the cellular response 
to DNA damage. 
Materials and Methods 
Cell Synchronization 
BHK cells were plated out at a density of 1  x  105 cells per 25-ram di- 
ameter culture dish for morphological studies, or at 3  ×  106 cells per 100- 
ram diameter dish for phosphorylation experiments. A double block method 
was then applied for synchronization. The cells were first arrested in RPMI 
culture medium containing 0.25%  calf serum for 48 h.  They were then 
released by replacing the low serum medium with regular growth medium 
(containing 10% calf serum), and aphidicolin was added to a concentration 
of 1 #g/ml for 24 h to arrest the cells at early S phase. The cells were then 
released into S by washing off the aphidicolin and incubating with regular 
growth medium. After 6 h, colcemid was added to a concentration of 0.3 
#g/ml to capture cells that enter metaphase. 
Drug Treatment 
VM-26 (Etoposide) was kindly provided by Dr.  W.  T.  Bradner, Bristol 
Laboratories.  Camptotbecin, aphidicolin, and colcemid were purchased 
from Sigma Chemical Co. (St. Louis, MO). All drugs except for colcemid 
were dissolved in DMSO at  1,000x  concentrations. Colcemid was dis- 
solved in PBS as 1,000×  stock. 
Fluorescence Microscopy  for 
Chromosome Morphology 
Both attached and floating cells were recovered by trypsinization and fixed 
with 3.7%  formaldehyde for 10 rain on ice. The fixed cells were pelleted 
by eentrifugation at 800 g for 5 rain and resuspended in PBS containing 1 
#g/ml of  the fluorescent DNA stain Hoechst 33258 (3). After 2-5 rain stain- 
ing, the cells were pelleted again and resuspended in 10 #1 Hanker Yates 
reagent containing 90% glycerol. The cells were mounted on glass slides 
and  viewed  through  a  Zeiss  Standard  microscope  equipped  with  an 
epifluorescence unit. Photographs were taken on 35 mm Kodak Technical 
Pan #2415  film at  100 ASA. Chromosome condensation was assessed by 
counting the percentage of cells with mitotic chromosomes and by monitor- 
ing their morphology. Several hundred cells were counted in different fields 
on each slide. The slides were coded and scrambled so that mitotic cells 
can be scored without knowledge of their treatment or their position in the 
cell cycle. 
Lamin Immunocytochemistry 
Rabbit antiserum against BHK lamins A, B, and C (kindly provided by R. 
Hancock, Laval University Cancer Research Center, Hotel Dieu Hospital, 
Quebec) was used at a dilution of 1:1,000. Cells were grown on polylysine- 
coated coverslips and immunocytochemistry was performed as described by 
Earushaw et al. (10), using TRITC-conjugated goat anti-rabbit IgG (Tago 
Inc., Budingame, CA) as the secondary antibody. The cells were also coun- 
terstained with Hoechst 33258  for visualization of the chromosomes. 
Histone Phosphorylation 
To examine G2 phase-related historic phosphorylation, synchronized cells 
were released from aphidicolin block in normal culture medium for 4 h, 
after which the medium was replaced by phosphate-free  medium containing 
10%  dialyzed calf serum.  32p-orthophosphoric acid was then added to a 
concentration of  25/~Ci/ml and the cells were incubated for the time periods 
specified in the figure legends. To extract histones, the medium was poured 
into a 50-ml polypropylene tube and centrifuged to collect any unattached 
cells. The cells that remained attached were harvested by trypsinization, 
and pooled with the pelleted cells from the medium. The cells were washed 
once with ice cold PBS before lysis in nuclei isolation buffer (250 mM su- 
crose,  1 mM CaCI2,  2  mM MgCI2,  1%  (vol/vol) Triton X-100,  10 mM 
Tris-HCl, pH 8.0) containing 10 raM NaE 50 mM iodoacetamide, 50 mM 
~-glycerophosphate, 50  mM NaHSO3,  and 2  mM  PMSE  The  nuclear 
pellets were collected by centrifugation at 10,000 g for 1 rain at 4°C, and the 
supernatant was discarded. To extract total histones, the nuclear pellet was 
extracted  twice  with  0.4  N  H2SO4 and  the  solubilized proteins  were 
The Journal  of Cell Biology,  Volume 111, 1990  1754 precipitated with 20% TCA. This precipitate was then washed twice with 
acetone, dried under vacuum, and solubilized  in acid-urea sample buffer 
(5% glacial acetic acid, 8 M urea, 5% glycerol).  To isolate histone H1, the 
nuclear pellet was extracted twice with 5% PCA, and the solubilized pro- 
teins were precipitated and washed as described for the total histones. The 
very lysine-rich proteins which included histone HI were then solubilized 
in acid-urea sample buffer containing 2.5 M urea instead of 8 M. 
Gel Electrophoresis  of Phosphorylated Histones 
Phosphorylated histones H1 and H3 were resolved in 25 ×  19 ×  0.15-cm 
acid-urea gels (12% acrylamide, 0.08% bisacrylamide, 5% acetic acid, and 
8 M urea), with 5 % acetic acid as the running buffer. After an overnight 
preelectrophoresis,  40/~g protein was loaded onto each lane and electropho- 
resis was carded out for 36 h at 350 V at 4 °. 
To examine the degree of phosphorylation of histone H1, we used the 
acid-urea gel system described by Langan (31). The 25 ×  19 ×  0.075-cm 
gel was composed of 15 % acrylamide, 0.1% bisacrylamide, 5 % acetic acid, 
and 2.5 M urea. The running buffer was 5 % acetic acid. After an overnight 
preelectrophoresis,  10 ~tg of the PCA extract was loaded onto each lane and 
electrophoresed for 48 h at 4~C at 350 V. 
At the completion of electrophoresis,  the gels were stained with Coomas- 
sie blue and dried before autoradiography using Kodak XAR 2 film to iden- 
tify the phosphorylated species.  The radioactivity of individual bands was 
quantitated with an Ambis radioactivity  scanner or by scanning autoradio- 
grams. Background readings were determined from adjacent areas of the 
gel. 
Assay of HI Kinase Activity In Vitro 
Crude nuclear extracts containing histone H1 kinase activity were prepared 
by a modification  of the method described by Lake (29). BHK cells were 
harvested from monolayer cultures by trypsinization and washed in cold 
PBS supplemented with 0.1 mM PMSE The cells were lysed with a Dounce 
homogenizer in 10 packed cell volumes  (PCVs) of buffer A (10 mM Tris- 
HCI,  pH 7.4,  10 mM NaC1,  10 mM j3-mereaptoethanol,  1.5 mM MgC12, 
1.0 mM CaCI2, 5 mM fl-glycerophosphate,  0.2 mM PMSF, 0101% polyoxy- 
ethylene 23-1anryl  ether  [Brij-35],  0.25  M  sucrose)  supplemented with 
0.5% Triton X-100. Nuclei were recovered by centrifugation at 1,000 g for 
10 rain, washed twice in buffer A, and pelleted after each wash by centrifu- 
gation.  Histone H1 kinase activity was solubilized by gentle vortexing  of 
nuclei suspended in one PCV of buffer B (20 mM Tris-HCl, pH 7.4, 5 mM 
~-mercaptoethanol, 0.1 mM PMSE 0.01% Brij-35,  10 mM/~-glycerophos- 
phate, 10% glycerol)  containing 0.4 M NaCI and 0.1 mM EDTA. The nu- 
clear homogenate was centrifuged at 20,000 g for 30 rain and H1 kinase ac- 
tivity was precipitated from the resulting supernatant with the addition of 
solid ammonium sulfate to 40 % saturation. The ammonium sulfate precipi- 
tate was collected by centrifugation at 20,000 g for 20 min and was resus- 
pended in 0.5 PCV of buffer B and dialyzed  against buffer B containing 5 
mM EDTA for 2 h. The dialyzed  sample was clarified by centrifugation at 
20,000  g for 10 rain. 
Histone HI kinase activity was assayed in a 10-#1 reaction mixture con- 
taining 50 mM Tris-HC1,  pH 7.4,  10 mM /3-mercaptoethanol,  0.1  mM 
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Figure  1.  Cell  synchroniza- 
tion. BHK cells were released 
from aphidicolin block at time 
0  and colcemid was added at 
time 6. Their progress through 
S  phase  and  G2+M  phases 
was  followed  by  collecting 
cells  at  different time  points 
and analyzing their DNA con- 
tent  by  flow  cytometry.  For 
the determination of M phase, 
additional time points were collected,  the cells were fixed,  their 
DNA stained with Hoechst 33258, and the mitotic cells were scored 
using fluorescent microscopy. The dashed line indicates the extent 
of the G2 phase;  S  phase ceils are  represented by open circles; 
G2+M phase cells are represented by filled circles; M  phase ceils 
are represented by open triangles. 
EGTA,  10 mM MgC12, 100 #M 7-32p-ATP (1,000 cpm/pmole) extract, and 
0.5 mg/ml HeLa histone H1 (generously  provided by J. W. Breneman and 
E Yau, University of California, Davis, California). Reactions were initiated 
by the addition of enzyme,  incubated for 10-15 rain at 30  °, and terminated 
by the addition of H3PO4 to a final concentration of 150 raM. Incorpora- 
tion of riP was quantitated by spotting 10-/zl aliquots onto P81 phosphocel- 
lulose paper (Whatman Inc., Clifton, NJ). P81 paper was washed four times 
in 75 mM H3PO4, once in acetone, dried, and counted in Beta-Max liquid 
scintillation cocktail (ICN K&K Laboratories Inc., Plainview, NY) (15). In- 
corporation of 32p specifically into histone H1 substrate was determined as 
the difference between reactions containing histone H1 substrate and control 
reactions in which no suhstrate was added. VM-26 and caraptothecin were 
prepared by serial dilutions in DMSO, and then diluted 10-fold in 1× assay 
buffer to yield 10×  stock solutions.  H1 kiaase activity was assayed in the 
presence of 1-150/~M VM-26 or camptothocin by the addition of 1/10 vol 
of the appropriate stock solution and further diluted 10×  in the reaction 
mixture. 
Pulse l~eld Gel Electrophoresis 
Mitotic cells were embedded in  0.5 % low-gelling agarose in cell culture medi- 
um. They were lysed and digested for 48 h at 37°C in 0.5 M EDTA, pH 7.4, 
0.9 % sarkosyl, 0.1% SDS, and 0.5 m~/rnl proteinase K. Electrophoresis  was 
in 1% agarosein 1× TBE at200V and 14  ° ona CHEF-DR II system (Bio-Rad 
Laboratories, Richmond, CA). Switching times were 70 s for 10 h followed by 
120 s for 9 h. The gels were then stained with ethidium bromide. 
Results 
Cell Synchronization 
BHK cells were synchronized using the double block method 
described above.  Fig.  1 shows the flow cytometric profiles 
of the cells as they progress synchronously through S, G2, 
and into M phase after release from aphidicolin block at the 
G1/S boundary. The cells were accumulated at mitosis by 
colcemid, an inhibitor of microtubule formation. The extent 
of the G2 phase was calculated by subtracting the percentage 
of mitotic cells from the percentage of cells in G2  +  M 
phase. G2 started at '~5 h after release from the aphidicolin 
block, peaked at '~7 h, and ended at ~8.5 h. Mitosis was 
observed to peak at 10-11 h. 
VM-26 Blocks G2 and M Phase Phasphorylation of 
Histone HI 
As cells progress through G2 into M, the level of phosphory- 
lation on histone H1 increases from two to three phosphates 
per molecule at early G2 to four to six phosphates per mole- 
cule, depending on the subtype of histone, at metaphase. To 
determine the level of phosphorylation, synchronized BHK 
cells were allowed to progress through the cell cycle in the 
presence of inorganic 32P-phosphate and colcemid to block 
the cells at metaphase.  At different times, cells were col- 
lected, histone H1 was selectively extracted with 5% PCA, 
and analyzed by electrophoresis using an acid-urea gel sys- 
tem to resolve the different phosphorylated forms of H1 (31). 
As illustrated in Fig. 2 A, lanes 1-4, the level of  phosphoryla- 
tion increased from a faster migrating, low phosphorylated 
form at early G2  (6 h) to slower migrating, highly phos- 
phorylated forms at mitosis (12 h). 
To examine the effect of VM-26, the drug was added to 
parallel cultures at 6, 7.5,  or 9 h, corresponding to early, 
mid, and late G2, respectively. The cells were then collected 
at the 12-h time point, corresponding to the time of mitosis, 
and the levels of histone H1  phosphorylation determined. 
Fig. 2 A, lanes 5-7, shows that in the presence of 5/~M VM- 
Roberge et al.  VM-26 and Histone HI Phosphorylation  1755 Figure 2. Effect of VM-26 and camptothecin on histone H1 phosphorylation. (A) 32po4 was added to synchronized cells 4.5 h after re- 
lease from aphidicolin  block. DMSO was added as a control to four cell aliquots  at 6 h, and the cells  were collected at 6, 7.5, 9, and 
12 h (lanes 1-4). At 6, 7.5, and 9 h, 5 txM VM-26 (lanes 5-7) or 5/zM camptothecin (lanes 8-10) was added to other aliquots  and the 
cells were harvested at 12 h. Histone H1 was extracted  and run on an acid-urea gel.  The upper panel shows the Coomassie blue-stained 
gel and the lower panel is the corresponding autoradiogram. The open arrowhead shows the migration of low phosphorylated forms of 
histone H1, and the filled arrowhead shows the migration of the hyperphosphorylated forms.  (B) The relative  H1 phosphorylation of the 
samples in A was determined by quantitating  the radioactivity associated with all HI bands in each lane, then dividing the amount of  protein 
determined from scans of the Coomassie blue-stained gel.  (filled circles) Cells  treated  with DMSO; (open triangles) cells treated with 
VM-26; (open squares) cells treated with camptothecin. C is as B except that the relative HI hyperphosphorylation is displayed,  as deter- 
mined from the radioactivity of the three slowest migrating radioactive  bands in A. 
26, H1 phosphorylation did not reach the high levels attained 
by control cells at mitosis (compare lanes 5,  6, and  7 with 
lane 4). Fig. 2 B shows the quantitation of the total radioac- 
tivity associated with histone H1 and confirms that the level 
of phosphorylation did not increase further upon incubation 
Table I. In Vitro Effects of VM-26 and Camptothecin on 
Histone HI Kinase Activity* 
Drug concentration  Relative H1  kinase activity 
/~M  % 
VM-26 
1  89 
3  95 
5  89 
30  90 
50  94 
150  101 
h 
camptothecin 
1  99  6.0 
3  85  7.5 
5  86  9.0 
30  98  11.0 
50  104 
150  98 
* Assay conditions were as described under Materials and Methods.  Each ac- 
tivity value was determined at least three times. The mean values of the deter- 
minations are  reported  relative to  control  reactions in which  no  drug was 
added. 
with VM-26.  In fact,  Fig.  2  B  reveals  that the level of H1 
phosphorylation actually decreased when the inhibitor was 
applied  at  7.5  and  at  9  h.  Analysis  of the  most  hyper- 
phosphorylated (the slowest migrating) forms of histone H1 
which are characteristic of the mitotic form of histone HI, 
shows that H1 hyperphosphorylation was blocked by VM-26 
at the 6 h, and noticeably decreased when the inhibitor was 
added at 7.5 or 9  h  (Fig.  2  B).  These results indicate that 
in addition to the inhibition of histone H1 phosphorylation, 
VM-26 induces partial  dephosphorylation. 
Table II. In Vivo Effects of VM-26 on Histone HI Kinase 
Activity: Relative Activity of  Histone HI Kinase 
Times after release 
from aphidicolin block  Control  VM-26 
1.0  0.5 
1.5  0.6 
1.8  1.5 
2.1 
Synchronized BHK cells were released from  aphidicolin arrest and  control 
samples were assayed for historic H1 kinase activity at the times indicated. For 
the VM-26-treated cells, 5/zM VM-26 were added to the cells at the times indi- 
cated after release from aphidicolin arrest, and the cells were harvested at the 
eleventh hour for assay of historic H1 kinase activity. Units of kinase activities 
are  expressed  relative to  the  control  sample taken  6  h  after  release  from 
aphidicolin block. 
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This  inhibition  of histone  H1  phosphorylation  was  unex- 
pected  and  we  investigated  the  possibility  that  VM-26 
directly inhibits  the  activity of histone  H1  kinase.  The  in 
vitro effect of VM-26 on the histone H1 kinase activity was 
measured using a crude nuclear extract. Histone H1 isolated 
from HeLa cells was used as the substrate for the GA kinase 
assay. Table I clearly shows that VM-26 has no inhibitory 
effect on H1 kinase activity up to  150/~M,  a concentration 
30-fold higher than that used for the above-mentioned ex- 
periments with living cells. Therefore, the observed inhibi- 
tion of H1 phosphorylation is not due to a direct effect of the 
drug on the kinase, nor is it a result of a general inhibition 
of protein phosphorylation since histone H2A phosphory- 
lation,  which is cell cycle-independent, was minimally af- 
fected by VM-26 (see Fig.  5  C). 
VM-26 Inhibits H1 Kinase Activity In Hvo 
Although VM-26 does not inhibit histone H1 kinase activity 
directly, it could have in vivo effects either by inhibiting the 
activation of the kinase or by promoting its inactivation. To 
examine this, synchronous cells were treated with VM-26 at 
6, 7.5, and 9 h, harvested at the time corresponding to mito- 
sis, and nuclear extracts containing the H1 kinase were pre- 
pared.  Nuclear extracts were also prepared from untreated 
cells harvested at 6, 7.5, 9, and 11 h. The results of the mea- 
surements of the kinase activities are summarized in Table 
II. In the absence of VM-26, H1 kinase activi[y increased as 
the cell progressed through G2 and into M.  When VM-26 
was added to the cells, the kinase activity did not increase. 
Instead, a marked decrease in activity was noted. This result 
indicates that VM-26 affects the activation or inactivation of 
histone H1  kinase. 
VM-26 Prevents Chromosome Condensation 
If, as has been proposed (4-6), H1 hyperphosphorylation is 
essential for chromosome condensation and entry into mito- 
sis, then, in the presence of VM-26, chromosome condensa- 
tion should not occur because of the absence of histone H1 
hyperphosphorylation.  VM-26 was added to synchronized 
cells at 6, 7, 8, 9,  10, or 11 h after release from aphidicolin 
arrest, and chromosome condensation was determined mor- 
phologically at the time of mitosis (12 h).  The condensed 
chromosomes were then  stained  with  the  fluorescent dye 
Hoechst 33258.  The slides were scrambled so that the ob- 
server would not know the time points that were analyzed or 
whether the cells were treated with drugs.  Several hundred 
cells were scored for each time point.  Fig.  3 A  shows that 
VM-26 completely prevented the formation of visibly con- 
densed  chromosomes when  added  at any time in  the  G2 
phase.  At the resolution afforded by light microscopy, the 
chromatin  of  VM-26-treated  cells  was  indistinguishable 
from that of untreated G2 cells at the time when VM-26 was 
added (see Fig. 4). This inhibition of chromosome condensa- 
tion was not observed when DMSO, the solvent for VM-26, 
was added to the ceils (Fig. 3 B). This inhibition of chromo- 
some condensation by VM-26 was concentration dependent, 
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Figure 3. Effect of VM-26 on chromosome condensation. (A) Cells 
synchronized as in Fig. 1 were collected at 1-h intervals and the per- 
centage of cells with visibly condensed chromosomes were deter- 
mined (closed circles). At 6, 7, 8, 9,  10, and  11 h, 5 #M VM-26 
was added and the percentage  of mitotic cells was determined  at 
12 h (open triangles) (B) In a parallel run, control cells were treated 
with DMSO at 6, 8, and 10 h and collected at 12 h (open circles). 
Figure 4. Effect of VM-26 and camptothecin on chromosome con- 
densation and nuclear lamina depolymerization.  DNA and lamins 
were visualized in the same cells by labeling with Hoechst 33258 
(A-D) and lamin antibodies (A'--D'). DMSO (A, A', B, B'), 5 ttM 
VM-26 (C, C"), or 5 #M camptothecin  (D,/7) were added at 9 h 
and the cells were harvested and fixed at 11 h. Control cells were 
fixed and stained at 9 h (A, A') and at 11 h (B, B'). Bar, 5 tim. 
Roberge et al. VM-26  and Histone HI Phosphorylation  1757 Figure 5. Effect of VM-26 and eamptothecin on the phosphorylation of histone H3 and histone H2A. In the same experiment as in Fig. 
2, aliquots of isolated nuclei were treated with sulfuric acid to extract core histones, and the proteins were separated in an acid-urea gel. 
The upper part of  A shows the proteins stained with Coomassie blue and the lower part shows the corresponding autoradiogram. B shows 
the quantitation of historic H3 phosphorylation and C shows the quantitation of histone H2A phosphorylation; both are expressed relative 
to the amount of  protein loaded as determined from the Coomassie blue-stained gel. (tilled  circles) Cells treated with DMSO; (open trian- 
gles) cells treated with VM-26; (open squares) cells treated with camptothecin. 
with a 50% inhibition observed at a concentration of 1.5/zM 
(data not shown). 
VM-26 Prevents Nuclear Lamina Disassembly and 
M Phase Phosphorylation of Histone 1-13 
At mitosis, the onset of chromosome condensation is accom- 
panied by phosphorylation of nuclear lamins, depolymeriza- 
tion of the nuclear lamina, and nuclear envelope breakdown 
at prometaphase. To determine if these events could occur 
independently of chromosome condensation and H1 phos- 
phorylation and be unaffected by VM-26, the fate of the nu- 
clear lamina was determined by immunofluorescence using 
antibodies  raised against  lamins  A,  B,  and  C  from BHK 
cells. The cells were counterstained with Hoechst 33258 to 
monitor the degree of condensation of the chromosomes. 
During interphase, the nuclear lamina surrounds the nucleus 
and lamin immunofluorescence is localized at the nucleus. 
Upon entry into mitosis, the breakdown of the nuclear enve- 
lope is accompanied by depolymerization of lamins, and im- 
munofluorescent  staining  shows  dispersal  of  the  lamins 
throughout the cytoplasm (Fig. 4). The addition of VM-26 
in early, mid, or late G2 (6, 7.5, and 9 h, respectively) clearly 
prevented lamina depolymerization. At the time of mitosis, 
the cells that were blocked from activating their H1 kinase, 
phosphorylating histones, and chromosome condensation by 
the presence of VM-26 all had intact nuclear lamina. 
Another mitosis-specific event is the phosphorylation of 
histone H3 at metaphase. As shown in Fig. 5, VM-26 also 
prevents this phosphorylation of histone H3. At the 9-h time 
point when a significant number of cells have already entered 
mitosis, a partial dephosphorylation of histone H3 can be 
observed. In the case of histone H2A which is phosphory- 
lated through the cell cycle, VM-26 was found to slow down 
phosphorylation  without  the  dephosphorylation  that  was 
seen with histones H1 and H3. 
Therefore, the addition of VM-26 during G2 phase blocks 
at  least  four  mitosis-related  events:  H1  phosphorylation, 
chromosome condensation,  nuclear lamina depolymeriza- 
tion, and histone H3 phosphorylation. 
VM-26 Induces Partial Unfolding of 
Metaphase Chromosomes and DNA Strand Breaks 
in Colcemid-arrested Cells 
In addition to preventing ceils from entering mitosis, VM-26 
also has a  striking effect on the morphology of metaphase 
chromosomes in colcemid-arrested cells.  Fig. 6  shows the 
appearance of chromosomes in cells that were treated with 
DMSO (Fig. 6 A and E) or VM-26 (Fig. 6, C, D, G, and H) 
as  revealed by staining  with Hoechst 33258.  In  untreated 
cells, the chromosomes displayed the typical X  shape with 
brightly  fluorescent and  well-defined chromatids.  DMSO 
alone did not have any visible effect on this morphology. In 
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strand  breaks  in  metaphase 
chromosomes by VM-26. Mi- 
totic cells (>95%)  were col- 
lected  by shake off  of colcemid- 
arrested  monolayers. DMSO 
(lane 2), 5/~M VM-26 (lane 
3),  or  5  #M  camptothecin 
(lane 4) was added for2 h, af- 
ter which the cells were em- 
bedded in agarose, lysed, and 
digested with proteinase K as 
described  in  Materials  and 
Methods. (lanes I and 5) Sac- 
charomyces cerevisiae chromo- 
somal DNA and Hind III di- 
gested lambda DNA. Agarose 
gel inserts in loading wells are 
shown at the top of the gel. 
Figure 6.  Effect of VM-26 and camptothecin on mitotic chromo- 
some morphology. Cells were treated with DMSO (A and E), 5 t~M 
camptothecin (B arid F), or 5 /~M VM-26 (C, D, G, H) for 2 h 
(A-D) or 3.5 h (E-H). The DNA was then stained with Hoechst 
33258. Bar, 5 t*m. 
contrast,  cells treated with VM-26 had chromosomes that 
appeared enlarged with more rounded and less fluorescent 
arms, and less defined edges. These chromosomes appeared 
partially decondensed.  1 h after the addition of VM-26, the 
chromosomes in several cells displayed such decondensed 
state. After 2 h, the chromosomes in every cell have adopted 
the partially unfolded conformation. With increasing times 
of exposure, the chromosomes become even more rounded 
and,  in many cases,  the X  shape became unrecognizable, 
making it difficult to score them as mitotic cells. This could 
be the reason for the decrease in number of mitotic cells after 
treatment of VM-26 (Fig.  3). 
In addition, double-stranded breaks in the DNA were de- 
tected with exposure to VM-26 (Fig. 7, lane 3). Pulsed field 
gel  electrophoresis  showed  a  fragmentation of the  DNA 
ranging from 20 to 800 kb, comparable with the 10-200 kb 
estimated for the sizes of DNA loops in mammalian chromo- 
somes. As revealed in lanes 2 and 4, DNA from untreated 
control (lane 2)  or the camptothecin-treated cells (lane 4) 
showed no fragmentation. 
The altered morphology of the chromosomes and inhibi- 
tion of entry into mitosis by VM-26 was not a result of cell 
death because exposure of ceils to 0.5-50/~M for up to 6 h 
did not cause any increase in the number of cells that took 
up trypan blue compared to untreated cells (data not shown). 
A  Topoisomerase I Inhibitor Blocks Histone 
HI Phosphorylation and Entry into Mitosis Only 
in Early GI 
A possible role of topoisomerase I on histone H1 phosphory- 
lation was also investigated using the specific inhibitor camp- 
tothecin. Like VM-26, camptothecin inhibits topoisomerase 
I by stabilizing the enzyme-DNA complex containing a sin- 
gle strand DNA break (32). Fig. 2 shows the effects of 5 #M 
camptothecin on histone H1 phosphorylation when applied 
in early, mid, or late G2. Quantitation of histone phosphory- 
lation in Fig. 2 B and H1 hyperphosphorylation in Fig. 2 C 
shows that camptothecin, like VM-26, completely inhibited 
HI phosphorylation when applied in early G2. However, the 
effects later in G2 differ markedly from that of VM-26. At 
the 7.5- and 9-h time points, camptothecin partially inhibited 
H1  phosphorylation without inducing and dephosphoryla- 
tion. Camptothecin had no effect on histone H1 kinase activ- 
ity in vitro (Table I).  Effects of camptothecin on the phos- 
phorylation of histone H2A were small, comparable to that 
of VM-26 (Fig.  5). 
Inhibition of chromosome condensation by camptothecin 
was seen only when applied at early G2 (Fig. 8). Similarly, 
the  inhibitor  prevented  nuclear  lamina  depolymerization 
when applied in early G2. The effects on histone H3 phos- 
phorylation were similar to that of H1  phosphorylation in 
that the phosphorylation was completely inhibited when the 
drug was added at early G2, and the level of  H3 phosphoryla- 
tion was reduced at late G2 (Fig. 5). Finally, camptothecin 
did not induce any unfolding of metaphase chromosomes 
(Fig. 6) nor did it induce any DNA strand breaks (Fig. 7). 
These results suggest that topoisomerase I may not be re- 
quired at late G2 for chromosome condensation and entry 
into mitosis. 
Discussion 
We have shown that the topoisomerase II inhibitor, VM-26, 
when applied in the G2 phase, has a number of unexpected 
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Figure 8. Effect of topoisom- 
erase  inhibitors  on chromo- 
some  condensation.  The in- 
hibitors  were  added  to  a 
concentration of 5/~M to syn- 
chronized cells  at  7  h  (top 
panel),  8 h (middle panel), 
and 9 h (bottom panel), and 
the percentage of mitotic cells 
was  determined  at  11  h. 
(closed circles) No treatment; 
(open circles) DMSO treated; 
(open triangles) VM-26 treat- 
ed;  (open squares) campto- 
thecin treated. 
effects: it blocks H1 phosphorylation and inhibits H1 kinase 
activity by acting on factors involved in the control of its ac- 
tivity, it prevents chromosome condensation, and it blocks 
other mitotic events such as nuclear lamina disassembly and 
histone H3 phosphorylation. In addition, VM-26 may act to 
reverse some of these processes. This was most obvious in 
mitotic cells where it could be shown that chromosomes par- 
tially decondense and that H1 and H3 become partially de- 
phosphorylated. It is possible that such a decondensation oc- 
curs  in  G2  phase  cells,  but  without  easy  morphological 
identification of chromatin condensation, we could not make 
such a distinction. 
Inhibition of  ill Kinase and of ill Phosphorylation 
in G2 Cells 
In cells that were exposed to VM-26 during the G2 phase, 
the activation of ill kinase and the increase in H1 phosphory- 
lation that would have occurred normally were completely 
blocked. Moreover, cells did not enter mitosis, as was deter- 
mined morphologically by the absence of condensed chro- 
mosome  and  nuclear  lamina  depolymerization,  and  bio- 
chemically by the absence of hyperphosphorylated histone 
H1  and H3.  However, an inherent limitation to the use of 
these drugs is that they do not allow the distinction between 
effects caused by inhibition of the enzyme per se and the 
effects due to the generation of DNA breaks.  Studies done 
on topoisomerase II mutants in yeast show that cells can en- 
ter mitosis in the absence of any enzyme activity (50). This 
would suggest that the observed G2 block in our study may 
not be due to the inhibition of the topoisomerase II activity 
but to DNA breaks caused by the action of VM-26. 
It is well documented that lesions in  DNA  induced by 
X-irradiation and other DNA-damaging agents arrest cells in 
the G2 phase (33, 34, 41).  Recent studies showing that cells 
deficient in DNA repair are hypersensitive to VM-26 suggest 
that DNA breaks caused by the drug are recognized by cells 
as DNA lesions even though these breaks remain covalently 
bound to topoisomerase II (25). In yeast, the gene RAD9 
was  identified to control the cell cycle response to DNA 
damage, and a mutation in this gene permits cells to enter 
mitosis despite DNA damage (20, 53). It was suggested that 
RAD9 functions as a negative regulator by inte~racting with 
proteins such as MPF or cyclins that participate in the com- 
mitment to mitosis (53). The arrest of BHK cells in G2 by 
VM-26 could operate through such a mechanism. As MPF 
and H1 kinase were shown to be the same, it is of interest 
that VM-26 not only prevents the activation of  the kinase, but 
promotes its deactivation. Hence, binding of  a negative regu- 
lator to the H1  kinase would be a  simple mechanism that 
would explain this dual effect. 
In the temperature-sensitive tsBN2 cell line derived from 
the BHK, premature chromosome condensation (PCC) can 
be induced in the G2 phase by shifting the cells up to the re- 
strictive temperature (40), and this can occur even when the 
cells are treated with DNA-damaging agents,  resulting in 
condensed but fragmented chromosomes. A mutation in the 
RCC1  gene relieves the  dependency of mitosis  on intact 
DNA in these cells at the restrictive temperature. However, 
we have observed that shift-up of  these cells to the restrictive 
temperature in the presence of VM-26 prevented PCC and 
histone  HI  phosphorylation (Th'ng,  J.,  M.  Roberge,  and 
E. M. Bradbury, manuscript in preparation). This raises the 
possibility that the G2 arrest caused by VM-26 is not depen- 
dent on a control mechanism for DNA repair. Obviously, 
more work will be necessary to clarify this point. 
Chromosome Condensation and Histone 
Dephosphorylation in Metaphase-arrested Cells 
A  second effect of VM-26 on cells was observed when the 
drug was added to metaphase-arrested cells. When histones 
H1  and H3 were partially dephosphorylated, the chromo- 
somes decondensed visibly, and double-stranded breaks oc- 
curred in the DNA.  There appears to be a correlation be- 
tween the level of phosphorylations on histones H1 and H3 
and the degree of condensation of the chromosomes. These 
results suggest that either active topoisomerase II or intact 
DNA is necessary for the maintenance of  the condensed state 
of metaphase chromosomes. 
The level of histone H1 phosphorylation is determined by 
the net phosphorylating activity that results from the activi- 
ties of the kinases and phosphatases. Partial or full inactiva- 
tion of  the kinases would result in a dephosphorylation of the 
substrate, as observed for H1 and H3. The effects of VM-26 
are specific to the control of H1 and H3 kinases because his- 
tone H2A phosphorylation appears to be unaffected. These 
changes in histone phosphorylation and chromosome con- 
densation probably constitute an intrinsic part of the cellular 
response to DNA damages such that the dephosphorylation 
of histones H1 and H3 would induce chromatin decondensa- 
tion,  thereby allowing the repair machinery access to the 
DNA. The partial decondensation was observed during mi- 
tosis when the chromosomes were visible under the light mi- 
croscope.  During  G2,  when  the  chromosomes  have  not 
sufficiently condensed to become visible under light micros- 
copy,  a  similar  decondensation of the  chromatin  can  be 
expected because the histones were similarly dephosphory- 
lated. These decondensation processes could be a determin- 
ing factor in the inability of the cells to initiate mitosis when 
the DNA is damaged. 
Camptothecin Does Not Block Entry into Mitosis in 
Mid and Late G2 Cells 
Camptothecin, the topoisomerase I inhibitor employed in this 
study, prevented entry in mitosis only when applied in early 
G2. It would appear that topoisomerase I does not play a di- 
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densation. This is consistent with results obtained with topo- 
isomerase I mutants in yeast showing that the ceils could 
proceed normally through the cell cycle in the absence of a 
functional topoisomerase I (49).  The inhibitory effects ob- 
served when camptothecin was applied in early G2 could be 
caused by interference with transcription of genes necessary 
for passage through G2 and subsequent entry into mitosis. 
It is significant that although camptothecin slowed down 
phosphorylation of histones HI and H3, no accompanying 
dephosphorylation was observed, nor was there any chromo- 
some decondensation in mitotic cells. The implication is that 
these dephosphorylation events are specific responses to the 
inhibition of topoisomerase II or to DNA strand breaks. 
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